| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |